These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A gold(i) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs. Schmidt C; Albrecht L; Balasupramaniam S; Misgeld R; Karge B; Brönstrup M; Prokop A; Baumann K; Reichl S; Ott I Metallomics; 2019 Mar; 11(3):533-545. PubMed ID: 30516775 [TBL] [Abstract][Full Text] [Related]
24. Palladium(II)-Indenyl Complexes Bearing N-Heterocyclic Carbene (NHC) Ligands as Potent and Selective Metallodrugs toward High-Grade Serous Ovarian Cancer Models. Bortolamiol E; Mauceri M; Piccolo R; Cavarzerani E; Demitri N; Donati C; Gandin V; Brezar SK; Kamensek U; Cemazar M; Canzonieri V; Rizzolio F; Visentin F; Scattolin T J Med Chem; 2024 Aug; 67(16):14414-14431. PubMed ID: 39119630 [TBL] [Abstract][Full Text] [Related]
25. Perceptible influence of Pd and Pt heterocyclic carbene-pyridyl complexes in catalytic diboration of cyclic alkenes. Pubill-Ulldemolins C; Bo C; Mata JA; Fernández E Chem Asian J; 2010 Feb; 5(2):261-4. PubMed ID: 20063347 [No Abstract] [Full Text] [Related]
26. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes. Ray S; Mohan R; Singh JK; Samantaray MK; Shaikh MM; Panda D; Ghosh P J Am Chem Soc; 2007 Dec; 129(48):15042-53. PubMed ID: 17988129 [TBL] [Abstract][Full Text] [Related]
27. N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery. Niu W; Chen X; Tan W; Veige AS Angew Chem Int Ed Engl; 2016 Jul; 55(31):8889-93. PubMed ID: 27311814 [TBL] [Abstract][Full Text] [Related]
28. Exploring nitrogen ligand diversity in trans-N-heterocyclic carbene-amine platinum complexes: synthesis, characterization, and application to fluorescence. Chardon E; Dahm G; Guichard G; Bellemin-Laponnaz S Chem Asian J; 2013 Jun; 8(6):1232-42. PubMed ID: 23559499 [TBL] [Abstract][Full Text] [Related]
29. Recent developments of metal N-heterocyclic carbenes as anticancer agents. Aher SB; Muskawar PN; Thenmozhi K; Bhagat PR Eur J Med Chem; 2014 Jun; 81():408-19. PubMed ID: 24858545 [TBL] [Abstract][Full Text] [Related]
30. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches. Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609 [TBL] [Abstract][Full Text] [Related]
31. Advances in metal-carbene complexes as potent anti-cancer agents. Gautier A; Cisnetti F Metallomics; 2012 Jan; 4(1):23-32. PubMed ID: 22027962 [TBL] [Abstract][Full Text] [Related]
32. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276 [TBL] [Abstract][Full Text] [Related]
34. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects. Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of Pd(II)-methyl complexes with N-heterocyclic carbene-amine ligands. Warsink S; de Boer SY; Jongens LM; Fu CF; Liu ST; Chen JT; Lutz M; Spek AL; Elsevier CJ Dalton Trans; 2009 Sep; (35):7080-6. PubMed ID: 20449151 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of amino-linked heterocyclic carbene palladium, gold, and silver complexes and their use as anticancer agents that act by triggering apoptotic cell death. Wang CH; Shih WC; Chang HC; Kuo YY; Hung WC; Ong TG; Li WS J Med Chem; 2011 Jul; 54(14):5245-9. PubMed ID: 21671598 [TBL] [Abstract][Full Text] [Related]
37. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs. Liu W; Gust R Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001 [TBL] [Abstract][Full Text] [Related]
38. A comparative study on dinuclear and multinuclear Ni(II), Pd(II), and Pt(II) complexes of a thiolato-functionalized, benzannulated N-heterocyclic carbene ligand. Yuan D; Huynh HV Inorg Chem; 2013 Jun; 52(11):6627-34. PubMed ID: 23679658 [TBL] [Abstract][Full Text] [Related]
39. Pharmacomodulation on Gold-NHC complexes for anticancer applications - is lipophilicity the key point? Zhang C; Maddelein ML; Wai-Yin Sun R; Gornitzka H; Cuvillier O; Hemmert C Eur J Med Chem; 2018 Sep; 157():320-332. PubMed ID: 30099254 [TBL] [Abstract][Full Text] [Related]
40. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents. Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]